Truncated forms of DNA-binding estrogen receptors in human breast cancer.

The likelihood a breast cancer will respond to antiestrogen therapy depends on the tumor content of immunoreactive or ligand-binding estrogen receptor (ER). To investigate the failure of many ER-positive breast cancers to respond to antiestrogen therapy, we examined by gel-shift assay the ability of...

Description complète

Détails bibliographiques

Publié dans:	J Clin Invest
Auteurs principaux:	Scott, G K, Kushner, P, Vigne, J L, Benz, C C
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Clinical Investigation 1991
Sujets:	Research Article
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC295419/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1864980/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI115356
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!